*°±Åv¤¤*
¥[¤J¤é´Á: Nov 2018
¤å³¹: 1,088
|
^¤å wiki google ½Ķ
³o¸Ì±´£¨ìªº¼Æ¦r¤w¸g¶W¹L30»õ¾¯¡]¦³ªº¨S¼g¼Æ¶q¡AµLªkpºâ¡^¡C 3¤ë½÷·ç»¡2021¦~©³²£¶q¥i¥H´£¨Ñ¨ì25»õ¾¯¡C ¨S¬Ý¨ì³¢¸³ªº¡A©Î³\¬O§Q¥Î¤W®ü´_¬Pªº¤@»õÃB«×¡H ¨ä¥L°ê®an¥LÅý¥X¨Ó¥i¯à«ÜÃø¡H¡I ¤Þ¥Î:
|
||||||||
2021-06-15, 09:32 PM
#91
|
Silent Member
¥[¤J¤é´Á: Mar 2017
¤å³¹: 0
|
¤Þ¥Î:
Pfizer¤£¬O11¤ë¤~¶i¤J¤T´Á. ©xºô¼g¤F¬O7/27¶}©l²Ä¤T´Á´ú¸Õ Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints ì¤å "The Phase 3 clinical trial of BNT162b2 began on July 27 and has enrolled 43,661 participants to date, 41,135 of whom have received a second dose of the vaccine candidate as of November 13, 2020. " Google½Ķ "BNT162b2 ªº 3 ´ÁÁ{§É¸ÕÅç©ó 7 ¤ë 27 ¤é¶}©l¡A¨´¤µ¤w©Û¶Ò¤F 43,661 ¦W°Ñ»PªÌ¡AºI¦Ü 2020 ¦~ 11 ¤ë 13 ¤é¡A¨ä¤¤ 41,135 ¤H¤w±µ¨ü²Ä¤G¾¯Ô¿ï¬Ì]¡C " |
|||
2021-06-15, 09:47 PM
#92
|
Major Member
¥[¤J¤é´Á: Aug 2006
¤å³¹: 174
|
¤Þ¥Î:
¤HÃþ±o¥H¥Í¦s ¤£¬O¦³¥ú¦³¤ô¦³¹ª« ¦Ó¬O¦³§Æ±æ ¬Y¤H¾ã¤Ñn¬Ì] ¬F©²ÀqÀq¤£»y ´N¬Oµ¹¤H§Æ±æ ¤£¥Î½|«ü´§©x «ü´§©x ¨Ã¨S¦³¯u¥¿¦b«ü´§ ¥L¥u¬OÓÄ묹«~ ¸Ü»¡³oÓÄ묹«~ ¥»¨Ó¥H¬°¥L¦b¥h¦~´N·|³QÄ묹±¼ ¨S·Q¨ì¥i¥H¬¡¨ì¤µ¦~ §ó·N¥~ªº ³oÓÄ묹«~©~µM¤µ¦~®tÂI³QÄ묹 쥻¥H¬°¤µ¦~¨Æ±¡¥i¥H¸¨¹õ ¨S·Q¨ì........................................................................ |
|
2021-06-16, 12:21 AM
#93
|
*°±Åv¤¤*
¥[¤J¤é´Á: Nov 2018
¤å³¹: 1,088
|
¤Þ¥Î:
¤Þ¥Î:
¥h¦~7/27·s»D½Z¬O¼g 2/3´Á¡C ¦Ü©ó¬°¤°»ò¡H¦³¤°»ò¤£¤@¼Ë¡Hn°Ý½÷·ç¡C ¹ê»Ú¦b¬ü°êªºÁ{§É¹êÅç¡A ¥»®×¥¿¦¡¦WºÙ¼g1/ 2 /3´Á¡A ¶}©l©ó2020/4/29¡A ¹wp¥Dnµ²§ô¤é¡G2021/11/2 ¹wp¬ã¨sµ²§ô¤é¡G2023/5/2 ¤T´ÁÀ³¸ÓÁÙ¨Sµ²§ô¡AÁÙn¤@¬q®É¶¡¡K¡K https://clinicaltrials.gov/ct2/show...8¡A#eligibility ¤Þ¥Î:
¦¹¤å³¹©ó 2021-06-16 12:28 AM ³Q GCVincent ½s¿è. |
|||
2021-06-16, 12:24 AM
#94
|
Golden Member
¥[¤J¤é´Á: Mar 2001 ±zªº¦í§}: «n¥[¦{ªºªª³õ
¤å³¹: 3,280
|
¦n¦n¯º...
³ßÅw¸ò§Y±N¶}©ñªº¬ü°ê¤ñ? ¬ü°ê 6/13 ¸¹ªº¼Æ¾Ú¬O ·s¼W½T¶E 12845, ¦º¤` 145, ´«ºâ¦¨¥xÆWªº¤H¤f¬O ·s¼W½T¶E 918 Ó ©M ¦º¤` 10. ¬ü°ê³ÌºGªº¼Æ¾Ú¬O¤@¤Ñ·s¼W½T¶E 300,779, ¦º¤` 4406. ´«ºâ¦¨¥xÆWªº¤H¤f¬O¤@¤Ñ·s¼W½T¶E 21,484 ©M ¦º¤` 315. ¬ü°ê²Öp½T¶E 3,340 ¸U¤H, ²Öp¦º¤` 60 ¸U¤H. ´«ºâ¦¨¥xÆWªº¤H¤f¬O ²Öp½T¶E 239 ¸U¤H, ²Öp¦º¤` 42,857¤H. §ÚÁÙ¨SÁ¿¨ì§Ú 14 Ó¤ëµLªk¥~¹, À¹¤f¸n¶W¹L 15 Ó¤ë. ¬ù¥b¦~ªº®É¶¡, ¤f¸n, °®¬~¤â, ®ø¬r¼QÃú, ®ø¬rÀã¯È¤y ³£¯Ê³f. ¦³ 3 Ӥ몺®É¶¡, ¥Õ¦Ì, ªwÄѳ£¯Ê³f. À\ÆU, ¹s°â¹êÅé°Ó©±, ¦Ê³f¤½¥q¤£ª¾¹D˳¬¤F¦h¤Ö. §Ú³o¸Ì¬Ì±¡Ãzµo¤F¶W¹L1¦~¤~¦³¬Ì]¥´, ¬Ì±¡¤~ºâ¬O±±¨î¦í. ¥xÆW¬Ì±¡Ãzµo¤F¦h¤[? 5¤ë¤¤¥H«e¬Ì]ÁÙ¨S¤Hn¥´, ¶ûªF¶û¦è. ¬ü°ê²{¦bÅwªï¥~°ê¤H¨Ó¥´¬Ì]. ¥xÆW¥ú¬O¦³¥I°·«O¶Oªº¹´¥Á´N³Q·í§@¬O¹Lµó¦Ñ¹«¤F, ÁÙÅý¨S¦³°·«Oªº¥~°ê¤H¨Ó¥´§K¶Oªº¬Ì]? §A¯uªºn©M¬ü°ê¤ñ?
__________________
I pimp therefore I am ¦¹¤å³¹©ó 2021-06-16 01:40 AM ³Q Puff Daddy ½s¿è. |
2021-06-16, 01:27 AM
#95
|
Silent Member
¥[¤J¤é´Á: Mar 2017
¤å³¹: 0
|
¤Þ¥Î:
PfizerÀ³¸Ó¬O§â¤G´Á¸ò¤T´Á¤@°_°µ phase II/III clinical trial ì¤å "Phase II/III clinical trials may also provide more information about the safety and side effects of the new treatment. Combining phases II and III may allow research questions to be answered more quickly or with fewer patients. Also called phase 2/phase 3 clinical trial." Google½Ķ "II/III ´ÁÁ{§É¸ÕÅç¤]¥i¯à´£¨Ñ¦³Ãö·sÀøªkªº¦w¥þ©Ê©M°Æ§@¥Îªº§ó¦h«H®§¡C ±N II ´Á©M III ´Á¬Ûµ²¦X¡A¥i¥H§ó§Ö¦a©Î¥Î§ó¤Öªº±wªÌ¦^µª¬ã¨s°ÝÃD¡C ¤]ºÙ¬° 2 ´Á/3 ´ÁÁ{§É¸ÕÅç" |
|
2021-06-16, 01:47 AM
#96
|
Golden Member
¥[¤J¤é´Á: Mar 2001 ±zªº¦í§}: «n¥[¦{ªºªª³õ
¤å³¹: 3,280
|
__________________
I pimp therefore I am |
2021-06-16, 02:23 AM
#97
|
Senior Member
¥[¤J¤é´Á: Apr 2017 ±zªº¦í§}: (¢£-_-)¢£ ~ ùäùä
¤å³¹: 1,288
|
«Ü¦n, ²ö¼w¯Ç¤£´±»¡¥´¬Ì]«áªº¶Ç¬V´ú¸Õªºµ²ªG,
¼b¥Í¤½¥q¤j¦ÑÁó¥X¨Ó»¡¦Ñ¹ê¸Ü¤F. ©Ò¥H§Ú¥ý«e´N»¡¤F, ²{¦bªºÀô¹Ò®Ú¥»¬OÃļtªº¤Ñ°ó, ¦Ê¦~¤@¹J¡I¦¬³Î´µæµo¤j°]´N¾a³oªi¤F. ¹j´XÓ¤ë´Nn¥´¤@ªi, ¯u¬O¤£µo°]¤]Ãø. ¥´¬Ì]¬Oµ¹«e½u¾Ô¤hÀ¹¿û²¯»P¬ÞµP, ¦ý¤£¬OÅý¥LA²ÂÀH«K¼ÉÅS¦b¦MÀI¤§¤U, ¨º·Ó¼Ën³QÃzÀYªº. ¥B¥´¬Ì]¤´¦³´X¸U¤À¤§¤@ªº·ÀI,¬Y¨Ç¦³¤p°ÝÃDªº¬Ì]ÁÙ·|µy°ª(¤£¤[«e¥xÆW¦³ÓÂå¥Í´NGG¤F) Á`¤§±oÅý±µºØªÌ±jÄ饿½TÆ[©À. ¥t¥~,¥u¯à¬èë³o¨ÇµÛ¦WªºÃÄ, ¤£·|³y¦¨ÄY«ªº«á¿ò¯g, ¤£µM°ÝÃD¥i¯à·|¹³¹q¼v¸Ìºtªº¨º¼Ë... ¨ºÔ£¹q¼v«Ü¦h¤H¬Ý¹L§a?
__________________
------------------------------------------------------ ¦A¦¸±j½Õ, ¥´¬Ì]¤£¬O¦Y¤FµL¼Ä¬P¬P, ¨º¥u¬O«OÅ@¦Û¤v¤£«¯g, ÁÙ¬O·|¶Ç¬V¡I ¦pªG ¨ä¥L¤H¥´¤F¬Ì]«oªù¤á¤j¶}¤Ï¦Ó³Q¬ï³z§â¯f¬r±a¶i¨Ó¤F«¨? ÃÄ°Ó¦´N»¡§ÜÅé¥u¯à«OÅ@¤£·|«¯g¥b¦~,¤§«án¦A¸É¥´¡I. ±q¨S«OÃÒ¤£·|·P¬V¡I »¡Ô£±µºØ²v¤C¦¨´N¯à¸sÅé§K¬Ì, ³o³£¬O°ò©ó¥´¬Ì]«á¤£·|·P¬Vªº¼Ò«¬, °ÝÃD²{¦bªº¬Ì]®Ú¥»¤£¬O³o¼Ë¡I °¸¶ýA«õ ²ö¨¯¯R¤@ÂP EQ©Ô´µ-A¾|§Z ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ (Youtube¼v¤ù)§¹³J¤F¨S·dÀY¤F ³£¸Ó©Ç¦ò©_¦h¸Ü (Youtube¼v¤ù) ¬ü°ê¬Ý¯f±b³æ: |
2021-06-16, 04:28 AM
#98
|
Amateur Member
¥[¤J¤é´Á: Oct 2008
¤å³¹: 40
|
§R................
¦¹¤å³¹©ó 2021-06-16 06:06 AM ³Q NT-MAN ½s¿è. |
2021-06-16, 05:55 AM
#99
|
Major Member
¥[¤J¤é´Á: Feb 2000
¤å³¹: 227
|
²{¦b³oÓ¯f¬r´N¬O·|¦s¦b¦a²y¤£·|®ø¥¢¤F
©Ò¥H¨¾°ô¹Ò¥~ªº ÁÙ¬O¤@¼Ë¤£¯à¥X¤J°ê §Ú·Q³o¤£¬O¤j®anªº ³Ì²×´N¬O¦Ò¬Ì]¥´¤@¥´ ¤£n«¯g´N¦n¤F ¥t¬Ì]¤]n°ê»Ú»{ÃÒªº¤~¯à¥X°ê ¤£µM¥X¥h¤U¾÷³õ¤£¬OÁÙn¦A¥´¤@°w |
2021-06-16, 07:06 AM
#100
|